{"ticker": {"uuid": "5340e2cf-ce51-4f68-818a-d7d2a6c6adc8", "symbol": "ALDVI", "name": "Advicenne S.A.", "exchange": "PAR", "country": "FR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Advicenne Secures Its Cash Runway to Q2 2027 through a Bond Financing of a Nominal Amount of up to \u20ac3.8 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNR21mazR4UnBveUlid1cwLXQydjFJQ2xLWFFrT1Q4TllfUm5oQ1M3a2dMOFo0QzdLOXRvT2pOZlBYUE1yaHFvVUFxaEU3Nk50dEI5S0U0SHJtbmhKR0tiTWlyaHhXbzBDRHh3c0YxbWVmZ2psVlVuSVlXc2hXYnFEVXViaWpPV19PODJGMExaeFp0TVZUaUpWdno5VTRKZDdIX0lmZGk5VFRtTjdwWUxFSEhwQWJRWE9YWjZoSzFlcWFKV1E4LWlmMl9KTTlLelJTRlRzMzJvTHpmbnNSc01xYVA1NmxRSUVI?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-22T17:08:05+00:00", "published_display": "22 Jun 2026 17:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advicenne gains marketing approval and reimbursement for Sibnayal in UAE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPV240YnRNdUtrbF9tRFBWWmsydUpock5vRnYyOVlJZzNRcDBham1ISmc5Ulh3T1pUWWYyb0tHWkV3eDA4cEMtaW1vTTdTYVE3ZWxWZlJkTkE2OFNzM2ZBbXFXeFpJSnFxV3dSUFp3VXF3UHFaeGVwVnphV3J4bFl6WGV4eW9mOXRDSnN1ejNhaUU0OXlTYXRGemc0RTRsZ005QzJ6azNLQlJRNWJ5d0JrTzBlUXloQU82?oc=5", "source_name": "The Pharma Letter", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Advicenne Secures Its Cash Runway to Q2 2027 through a Bond Financing of a Nominal Amount of up to \u20ac3.8 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNR21mazR4UnBveUlid1cwLXQydjFJQ2xLWFFrT1Q4TllfUm5oQ1M3a2dMOFo0QzdLOXRvT2pOZlBYUE1yaHFvVUFxaEU3Nk50dEI5S0U0SHJtbmhKR0tiTWlyaHhXbzBDRHh3c0YxbWVmZ2psVlVuSVlXc2hXYnFEVXViaWpPV19PODJGMExaeFp0TVZUaUpWdno5VTRKZDdIX0lmZGk5VFRtTjdwWUxFSEhwQWJRWE9YWjZoSzFlcWFKV1E4LWlmMl9KTTlLelJTRlRzMzJvTHpmbnNSc01xYVA1NmxRSUVI?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-22T17:08:05+00:00", "published_display": "22 Jun 2026 17:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advicenne gains marketing approval and reimbursement for Sibnayal in UAE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPV240YnRNdUtrbF9tRFBWWmsydUpock5vRnYyOVlJZzNRcDBham1ISmc5Ulh3T1pUWWYyb0tHWkV3eDA4cEMtaW1vTTdTYVE3ZWxWZlJkTkE2OFNzM2ZBbXFXeFpJSnFxV3dSUFp3VXF3UHFaeGVwVnphV3J4bFl6WGV4eW9mOXRDSnN1ejNhaUU0OXlTYXRGemc0RTRsZ005QzJ6azNLQlJRNWJ5d0JrTzBlUXloQU82?oc=5", "source_name": "The Pharma Letter", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 54, "total_relevant": 2, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 1, "score": 54, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "liquidity", "primary_label": "Balance sheet", "confidence": 58, "events": [{"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.09, "latest_week": "2026-06-19", "one_week_move": -2.0, "four_week_move": 28.0, "twelve_week_move": -30.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.921263, "market_dynamics_buy_signal": false, "relative_strength": -30.906946, "fair_value_gap": -40.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 46.9219, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.0% over one week, +28.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Balance sheet", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "marketscreener.com", "count": 1}, {"label": "The Pharma Letter", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Balance sheet", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Balance sheet", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.0% over one week, +28.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Advicenne Secures Its Cash Runway to Q2 2027 through a Bond Financing of a Nominal Amount of up to \u20ac3.8 Million"}], "updated_at": "2026-06-23T03:06:29.656461+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}